EMA issues advice on casirivimab and imdevimab antibody cocktail for the treatment of mild-to-moderate COVID-19

    NEXT STORY
    Skylight Health Appoints Andrew Elinesky as Chief Financial Officer
    PREV STORY
    Ascendis Pharma A/S Announces New “Outgrow GHD” Educational Resource to Support Rare Disease Day 2021
    Subscribe to PM360
    Print Subscription
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Orphazyme reports encouraging arimoclomol clinical trial top-line data in Niemann-Pick disease Type C (NPC)

    Orphazyme A/SCompany announcement                                                                                                                   No. 12/2018                                                                                                                                        Company Registration No. 32266355                                                                                                                                                                                              Arimoclomol was well-tolerated in patients ...

    author_avatar
    NASDAQ Market News

    Aevitas Therapeutics Appoints Markus Peters, Ph.D., M.Sc., as Chief Executive Officer

    author_avatar
    NASDAQ Market News

    Cue Biopharma Begins Dosing Cohort 5 in an Ongoing Phase 1 Monotherapy Trial of CUE-101 in HPV+ Recurrent/Metastatic Head and Neck Cancer

    author_avatar
    NASDAQ Market News